Your browser is no longer supported. Please, upgrade your browser.
Settings
SPNC The Spectranetics Corporation daily Stock Chart
SPNC [NASD]
The Spectranetics Corporation
Index- P/E- EPS (ttm)-1.35 Insider Own1.10% Shs Outstand43.18M Perf Week-0.53%
Market Cap1.23B Forward P/E- EPS next Y-0.75 Insider Trans-3.68% Shs Float42.46M Perf Month1.25%
Income-58.10M PEG- EPS next Q-0.35 Inst Own94.50% Short Float9.12% Perf Quarter14.29%
Sales270.80M P/S4.53 EPS this Y3.40% Inst Trans0.97% Short Ratio13.26 Perf Half Y17.16%
Book/sh1.72 P/B16.51 EPS next Y38.00% ROA-13.30% Target Price30.83 Perf Year97.22%
Cash/sh1.32 P/C21.44 EPS next 5Y15.00% ROE-66.00% 52W Range13.81 - 29.00 Perf YTD15.92%
Dividend- P/FCF- EPS past 5Y21.06% ROI-11.60% 52W High-2.07% Beta1.61
Dividend %- Quick Ratio1.60 Sales past 5Y16.30% Gross Margin74.80% 52W Low105.65% ATR0.81
Employees960 Current Ratio2.00 Sales Q/Q10.30% Oper. Margin-16.10% RSI (14)57.99 Volatility3.44% 2.54%
OptionableYes Debt/Eq4.17 EPS Q/Q-16.80% Profit Margin-21.50% Rel Volume0.49 Prev Close27.95
ShortableYes LT Debt/Eq3.83 EarningsFeb 23 AMC Payout- Avg Volume292.09K Price28.40
Recom1.80 SMA201.02% SMA506.21% SMA20018.81% Volume143,846 Change1.61%
Dec-16-16Initiated Raymond James Outperform
Oct-21-16Reiterated Needham Buy $27 → $32
Aug-09-16Downgrade Needham Strong Buy → Buy $27
Aug-03-16Upgrade UBS Sell → Buy $10 → $30
Aug-01-16Reiterated RBC Capital Mkts Sector Perform $17 → $24
Jul-29-16Reiterated Needham Strong Buy $21 → $27
Jun-09-16Initiated Guggenheim Buy
Apr-26-16Downgrade Craig Hallum Buy → Hold
Feb-26-16Reiterated Stifel Buy $25 → $20
Feb-26-16Reiterated Needham Strong Buy $22 → $21
Feb-25-16Reiterated Dougherty & Company Buy $33 → $25
Oct-23-15Reiterated Needham Strong Buy $24 → $22
Sep-22-15Initiated The Benchmark Company Buy $24
Aug-18-15Upgrade Needham Buy → Strong Buy $24
Jul-30-15Upgrade Northland Capital Market Perform → Outperform $25
Jul-24-15Reiterated Stifel Buy $34 → $25
Jul-24-15Reiterated Needham Buy $39 → $24
Jul-24-15Reiterated Dougherty & Company Buy $45 → $33
Apr-27-15Upgrade Northland Capital Under Perform → Market Perform $25
Apr-24-15Reiterated Stifel Buy $38 → $34
Mar-02-17 01:25PM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017
01:04PM  SPECTRANETICS CORP Financials
Feb-27-17 11:02AM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27, 2017
Feb-24-17 04:54PM  SPECTRANETICS CORP Files SEC form 10-K, Annual Report +5.65%
Feb-23-17 10:17PM  Edited Transcript of SPNC earnings conference call or presentation 23-Feb-17 9:30pm GMT
05:01PM  Spectranetics reports 4Q loss
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:06PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million GlobeNewswire
07:07AM  Q4 2016 Spectranetics Corp Earnings Release - After Market Close
Feb-02-17 04:01PM  Spectranetics Announces Fourth Quarter 2016 Conference Call GlobeNewswire
Jan-24-17 06:13AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:00AM  ILLUMENATE Global 12-month Results Validate Stellarexs Top-tier Performance in Complex Patient Populations GlobeNewswire
Jan-20-17 04:22PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-11-17 09:16AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:00AM  Spectranetics Names Scott Hutton as General Manager, Vascular Intervention GlobeNewswire
Dec-28-16 04:05PM  Spectranetics to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-16-16 07:41AM  Coverage initiated on Spectranetics by Raymond James
Dec-12-16 10:37AM  The Spectranetics Corp. Value Analysis (NASDAQ:SPNC) : December 12, 2016
Dec-09-16 07:23AM  The Spectranetics Corp. breached its 50 day moving average in a Bullish Manner : SPNC-US : December 9, 2016
Dec-06-16 09:56AM  Hedge Funds Are Betting On Kraton Corp (KRA) at Insider Monkey
Dec-01-16 01:37PM  Hedge Funds Are Finally Buying Scientific Games Corp (SGMS) Again at Insider Monkey
Nov-30-16 06:22AM  Spectranetics Corp (SPNC)Hedge Funds Are Snapping Up at Insider Monkey
Nov-22-16 12:26PM  ETFs with exposure to The Spectranetics Corp. : November 22, 2016
Nov-21-16 04:05PM  Spectranetics Receives CE Mark for Stellarex 0.014 Drug-Coated Balloon GlobeNewswire
07:09AM  The Spectranetics Corp. breached its 50 day moving average in a Bullish Manner : SPNC-US : November 21, 2016
Nov-18-16 01:21PM  QT Vascular Announces That The Federal Circuit Denies AngioScore Petition For Rehearing PR Newswire
Nov-14-16 06:44AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure
Nov-07-16 09:00AM  Spectranetics to Attend Upcoming Investor Conferences GlobeNewswire
Nov-02-16 02:13PM  ETFs with exposure to The Spectranetics Corp. : November 2, 2016
09:18AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:15AM  Stellarex ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials GlobeNewswire
08:00AM  Spectranetics Files PMA Application for FDA Approval of the Stellarex Drug-Coated Balloon GlobeNewswire
Nov-01-16 06:44AM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report
Oct-31-16 10:56AM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
09:47AM  Spectranetics gets vote of confidence
Oct-28-16 02:14PM  Edited Transcript of SPNC earnings conference call or presentation 27-Oct-16 8:30pm GMT
Oct-27-16 06:37PM  Spectranetics reports 3Q loss
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:04PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million GlobeNewswire
07:07AM  Q3 2016 Spectranetics Corp Earnings Release - After Market Close
Oct-15-16 07:46AM  3 Cardiac-Care Stocks That Could Bring Heart-Stopping Gains at Motley Fool
Oct-12-16 08:46AM  The Spectranetics Corp. breached its 50 day moving average in a Bearish Manner : SPNC-US : October 12, 2016
Oct-06-16 04:05PM  Spectranetics Announces Third Quarter 2016 Conference Call and Upcoming Webcast at the Transcatheter Cardiovascular Therapeutics Conference GlobeNewswire
Sep-28-16 10:37AM  The Spectranetics Corp. Value Analysis (NASDAQ:SPNC) : September 28, 2016
Sep-27-16 08:32AM  The Spectranetics Corp. breached its 50 day moving average in a Bearish Manner : SPNC-US : September 27, 2016
Sep-22-16 11:25AM  ETFs with exposure to The Spectranetics Corp. : September 22, 2016
Aug-11-16 01:10PM  ETFs with exposure to The Spectranetics Corp. : August 11, 2016 +7.22%
06:03AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aug-10-16 05:59PM  First Randomized Trial of the Stellarex Drug-coated Balloon Presented at the Amputation Prevention Symposium GlobeNewswire
09:09AM  SPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Spectranetics Receives CE Mark for AngioSculptX GlobeNewswire
Aug-09-16 12:04PM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Jul-29-16 06:44AM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report +7.96%
01:05AM  Edited Transcript of SPNC earnings conference call or presentation 28-Jul-16 8:30pm GMT
Jul-28-16 05:45PM  Spectranetics reports 2Q loss
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:11PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million GlobeNewswire
07:07AM  Q2 2016 Spectranetics Corp Earnings Release - After Market Close
Jul-25-16 08:19AM  QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment PR Newswire
Jul-21-16 02:56PM  Federal Circuit Court's Mixed Ruling In Patent Appeal Case
01:34PM  SPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:21PM  Federal Circuit Court Rules in Appeal GlobeNewswire
Jul-20-16 09:00AM  12-month Results of the ILLUMENATE European Randomized Clinical Trial to be Presented at the Amputation Prevention Symposium GlobeNewswire +5.19%
Jul-07-16 09:00AM  Spectranetics to Host Second Quarter 2016 Conference Call on July 28, 2016 GlobeNewswire
Jun-27-16 04:31PM  The Spectranetics Corp. Value Analysis (NASDAQ:SPNC) : June 27, 2016 -5.86%
Jun-24-16 05:46PM  ETFs with exposure to The Spectranetics Corp. : June 24, 2016
08:45AM  The Spectranetics Corp. breached its 50 day moving average in a Bullish Manner : SPNC-US : June 24, 2016
Jun-23-16 04:17PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jun-15-16 04:07PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jun-13-16 11:43AM  SPECTRANETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-07-16 05:21PM  SPECTRANETICS CORP Files SEC form 8-K, Other Events
Jun-01-16 04:00PM  Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics Stellarex drug-coated balloon at NCVH GlobeNewswire
May-12-16 03:45PM  ETFs with exposure to The Spectranetics Corp. : May 12, 2016
May-11-16 04:00PM  Spectranetics to Present at the UBS Global Healthcare Conference GlobeNewswire
May-10-16 12:54PM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q1, 2016 By the Numbers
Apr-29-16 03:29PM  ETFs with exposure to The Spectranetics Corp. : April 29, 2016
07:40AM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report
03:01AM  Edited Transcript of SPNC earnings conference call or presentation 28-Apr-16 8:30pm GMT
Apr-28-16 07:28PM  Spectranetics reports 1Q loss -7.64%
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:15PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:00PM  Spectranetics Achieves First Quarter 2016 Revenue of $62.9 million GlobeNewswire
07:07AM  Q1 2016 Spectranetics Corp Earnings Release - After Market Close CCBN
Apr-26-16 06:54AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -5.79%
06:30AM  12-Month Interim ILLUMENATE Global Study Data Presented on Spectranetics Stellarex drug-coated balloon at Charing Cross GlobeNewswire
Apr-07-16 04:00PM  Spectranetics to Host First Quarter 2016 Conference Call on April 28, 2016 GlobeNewswire
Mar-24-16 04:16PM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:00PM  Spectranetics Names Udo Scheiner as Senior Vice President, International Operations GlobeNewswire
Mar-18-16 03:32PM  ETFs with exposure to The Spectranetics Corp. : March 18, 2016
Mar-07-16 12:58PM  The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q4, 2015 By the Numbers
Feb-29-16 08:20AM  The Spectranetics Corp. breached its 50 day moving average in a Bullish Manner : SPNC-US : February 29, 2016
Feb-26-16 08:46AM  SPECTRANETICS CORP Files SEC form 10-K, Annual Report +11.03%
12:06AM  Edited Transcript of SPNC earnings conference call or presentation 25-Feb-16 9:30pm GMT
Feb-25-16 04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:13PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:05PM  Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million GlobeNewswire
07:07AM  Q4 2015 Spectranetics Corp Earnings Release - After Market Close
The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to cross, prepare, and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention (VI) portfolio of VI devices includes laser and aspiration catheters; scoring balloon catheters, which supports catheters; and drug-coated balloon catheters. It also offers laser systems for use in various minimally invasive cardiovascular procedures; and sells, rents, and services its laser systems. The company's primary crossing products include Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme support catheters; and coronary vascular intervention products comprise ELCA Laser Ablation Catheter and AngioSculpt scoring balloon catheters for crossing and vessel preparation, as well as QuickCat aspiration catheter for thrombus management. Its lead management product line comprises excimer laser sheaths, non-laser mechanical sheaths, and cardiac lead management accessories as well as Bridge occlusion balloon catheters for the removal of pacemaker and defibrillator cardiac leads. In addition, the company offers the Stellarex DCB platform that is designed to treat peripheral arterial disease. The company sells its products directly, as well as through its distributors in the United States, Canada, Europe, the Middle East, the Asia Pacific, Japan, China, Russia, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McMahan Stacy PowellCFOMar 17Sale28.602,86481,91517,411Mar 21 04:14 PM
Matin ShahriarChief Operating OfficerMar 02Option Exercise10.9010,000109,000129,450Mar 03 05:47 PM
RUGGIO JOSEPH MDirectorJan 19Sale25.0110,000250,13368,186Jan 19 05:20 PM
McMahan Stacy PowellCFOJan 11Sale24.702907,163926Jan 11 07:17 PM
Matin ShahriarChief Operating OfficerJan 08Option Exercise0.004,430074,037Jan 10 05:12 PM
Drake Scott WilliamPresident, CEOJan 08Option Exercise0.005,5370143,995Jan 10 05:11 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMJan 08Option Exercise0.001,10804,600Jan 10 05:11 PM
McMahan Stacy PowellCFOJan 08Option Exercise0.001,93801,938Jan 10 05:11 PM
RUGGIO JOSEPH MDirectorDec 21Sale25.005,000125,00078,186Dec 21 04:32 PM
Drake Scott WilliamPresident, CEODec 17Option Exercise0.009680138,908Dec 20 05:10 PM
RUGGIO JOSEPH MDirectorAug 11Sale25.005,000125,00083,186Aug 12 05:01 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMJul 10Option Exercise0.0075403,726Jul 12 04:05 PM
Matin ShahriarChief Operating OfficerJul 10Option Exercise0.002,372070,365Jul 12 04:05 PM
Drake Scott WilliamPresident, CEOJul 10Option Exercise0.009,8790144,941Jul 12 04:05 PM
Matin ShahriarChief Operating OfficerJun 25Option Exercise0.001,622068,511Jun 28 05:07 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMJun 25Option Exercise0.0085403,237Jun 28 05:07 PM
Drake Scott WilliamPresident, CEOJun 25Option Exercise0.008,6000139,067Jun 28 05:08 PM
Drake Scott WilliamPresident, CEOJun 11Option Exercise0.007,0310133,742Jun 14 06:26 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMJun 11Option Exercise0.001,12502,732Jun 14 06:25 PM
Matin ShahriarChief Operating OfficerJun 11Option Exercise0.004,219068,221Jun 14 06:26 PM